AstraZeneca PLC ADR

ISIN US0463531089

 | 

WKN 886715

Market cap (in EUR)
240,863 m
Country
United Kingdom
Sector
Healthcare
Dividend yield
1.66%
 

Overview

Description

AstraZeneca characterizes itself as a pure-play biopharmaceutical company to span the entire value chain of a medicine from discovery, early- and late-stage development to manufacturing and distribution and the global commercialization of primary care, specialty care-led and specialty care medicines that transform lives. The group's primary focus is on three important areas of healthcare, namely "Cardiovascular and Metabolic disease", "Oncology" and "Respiratory, Inflammation and Autoimmunity". It is also active in the Infection, Neuroscience and Gastrointestinal disease areas. AstraZeneca operates in more than 100 countries worldwide.
Source: AfU Research GmbH
Show more Show less
Healthcare Biopharmaceuticals Other Biopharmaceuticals United Kingdom

Financials

Key metrics

Market capitalisation, EUR 240,863 m
EPS, EUR 2.75
P/B ratio 6.3
P/E ratio 30.5
Dividend yield 1.66%

Income statement (2024)

Revenue, EUR 50,010 m
Net income, EUR 6,506 m
Profit margin 13.01%

What ETF is AstraZeneca PLC ADR in?

There are 2 ETFs which contain AstraZeneca PLC ADR. All of these ETFs are listed in the table below. The ETF with the largest weighting of AstraZeneca PLC ADR is the Leverage Shares -5x Short Nasdaq 100 ETP.
ETF Weight Investment focus Fund size (in m EUR)
Leverage Shares 5x Long Nasdaq 100 ETP 0.38%
Equity
United States
Technology
28
Leverage Shares -5x Short Nasdaq 100 ETP 0.38%
Equity
United States
Technology
5
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.